Wednesday, December 09, 2015 12:57:14 AM
I think Linda made the decision that she had to regarding Ondra. This whole thing is the most bizarre story I've ever seen. I'm just uncomfortable with the shift in focus away from the internal governance concerns. So what if they find several hedge funds that sold short and manipulated the stock. I hate it with a passion, but I am doubtful that any justice would ever come of it.
Manipulation happens all the time and regulators consistently turn a blind eye. Even the deep capture and crew reports haven't been able to generate any action. How is proving manipulation and short selling going to help us secure future financing or create additional value. That's what NW wanted Ondra to provide and it's a gap he obviously wanted to address. I was hopeful they could help. Well the issue still exists and today LP eliminated my hope for a remedy of the problem in the near future. Have you looked at a chart lately? I'm starting to wonder if nwbo will be able to survive this.
Manipulation happens all the time and regulators consistently turn a blind eye. Even the deep capture and crew reports haven't been able to generate any action. How is proving manipulation and short selling going to help us secure future financing or create additional value. That's what NW wanted Ondra to provide and it's a gap he obviously wanted to address. I was hopeful they could help. Well the issue still exists and today LP eliminated my hope for a remedy of the problem in the near future. Have you looked at a chart lately? I'm starting to wonder if nwbo will be able to survive this.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
